Literature DB >> 23264190

Intraocular penetration of itraconazole in patient with fungal endophthalmitis.

Kiyofumi Mochizuki1, Yoshiaki Niwa, Kyoko Ishida, Hideaki Kawakami.   

Abstract

The purpose of this study was to determine the penetration of itraconazole, a type of azole antifungal agent, into the aqueous humor and vitreous after repeated oral administrations. Fungal endophthalmitis developed bilaterally in a 21-year-old man who had a history of intravenous hyperalimentation following abdominal surgery. Itraconazole capsules (200 mg/day) were taken orally for 12 consecutive days. Vitrectomy was performed on the left eye 30 h after the last oral itraconazole. Samples of blood, aqueous, and vitreous were collected during the vitrectomy. The concentration of itraconazole was determined by high performance liquid chromatography. The concentration of itraconazole was 0.492 μg/mL in the plasma, 0.020 μg/mL in the vitreous, and none in the aqueous of the left eye. Although no fungal organisms were isolated from the plasma and vitreous samples from both eyes, fungal DNA was detected in the vitreous from the left eye. Our findings indicate that oral itraconazole has limited penetration in eyes with fungal endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264190     DOI: 10.1007/s10792-012-9696-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  9 in total

1.  Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.

Authors:  Isabel Spriet; Lien Delaere; Katrien Lagrou; Willy E Peetermans; Johan Maertens; Ludo Willems
Journal:  J Antimicrob Chemother       Date:  2009-08-14       Impact factor: 5.790

2.  Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis.

Authors:  N A Rao; A A Hidayat
Journal:  Am J Ophthalmol       Date:  2001-08       Impact factor: 5.258

3.  Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.

Authors:  D V Savani; J R Perfect; L M Cobo; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

4.  Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene.

Authors:  T G Buchman; M Rossier; W G Merz; P Charache
Journal:  Surgery       Date:  1990-08       Impact factor: 3.982

5.  Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).

Authors:  Michael A Pfaller; Mariana Castanheira; Shawn A Messer; Gary J Moet; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2011-01       Impact factor: 2.803

Review 6.  Oral antifungals as prophylaxis in haematological malignancy.

Authors:  A G Prentice; P Donnelly
Journal:  Blood Rev       Date:  2001-03       Impact factor: 8.250

Review 7.  The clinical pharmacokinetics of itraconazole: an overview.

Authors:  J Heykants; A Van Peer; V Van de Velde; P Van Rooy; W Meuldermans; K Lavrijsen; R Woestenborghs; J Van Cutsem; G Cauwenbergh
Journal:  Mycoses       Date:  1989       Impact factor: 4.377

Review 8.  Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Authors:  J Singh; B Burr; D Stringham; A Arrieta
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

9.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

  9 in total
  2 in total

Review 1.  Etiological agents of fungal endophthalmitis: diagnosis and management.

Authors:  Rubens C Vilela; Luiza Vilela; Priscila Vilela; Raquel Vilela; Roberta Motta; Ana Paula Pôssa; Cirênio de Almeida; Leonel Mendoza
Journal:  Int Ophthalmol       Date:  2013-10-01       Impact factor: 2.031

Review 2.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.